• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Compared with the extensive data on left‐sided infective endocarditis (IE), there is much
less published information on the features and management of right‐sided IE. Right‐sided …

Force. The finalized document is approved by the CPG for publication in the European Heart
Journal. The Guidelines were developed after careful consideration of the scientific and …

Background The impact of pulmonary valve replacement (PVR) on major adverse clinical
outcomes in patients with repaired tetralogy of Fallot (rTOF) is unknown. Objectives The …

Background There are limited published data focused on outcomes of transcatheter
pulmonary valve replacement (TPVR) with either a Sapien XT or Sapien 3 (S3) valve …

Background Endocarditis has emerged as one of the most impactful adverse events after
transcatheter pulmonary valve replacement (TPVR), but there is limited information about …

Background: The Melody valve was developed to extend the useful life of previously
implanted right ventricular outflow tract (RVOT) conduits or bioprosthetic pulmonary valves …

Objective To define the incidence and risk factors for infective endocarditis (IE) following
surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI) …

Objectives Infective endocarditis is a life-threatening complication of congenital heart
disease (CHD), but there are few studies concerning the contemporary risk profile …

Abstract Background Congenital Heart Disease (CHD) predisposes to Infective Endocarditis
(IE), but data about characterization and prognosis of IE in CHD patients is scarce. Methods …